Save time and get answers to complex questions with AI chat
Patent term adjustment semaglutida?Dabrafenib and trametinib price?Drugpatentwatch skyrizi biologic patent analysis?Can wine consumption affect lipitor's cholesterol lowering ability?Alogliptin benzoate cost?
See the DrugPatentWatch profile for Edarbyclor
Edarbyclor (azilsartan medoxomil + chlorthalidone) is indicated for the treatment of essential (primary) hypertension in adults when blood pressure is not adequately controlled with azilsartan medoxomil or chlorthalidone alone [1].
The combination is used when monotherapy with either azilsartan medoxomil or chlorthalidone does not bring blood pressure under adequate control [1].
No—its listed indication is for essential hypertension in adults, as a combination therapy for inadequate response to the individual components [1].
Other Questions About Edarbyclor :